Abstract:
In the past decade, the world has witnessed the explosive growth of a multi-billion-dollar industry known as functional foods/nutraceuticals/phytomedicines/Ayurceutical. Nutra(Ayur)ceuticals appear to be of benefit in both the treatment and prevention of disease. Nutra(Ayur)ceuticals often possess unique chemical actions that are unavailable in pharmaceuticals. The human has been using food bioactive and/or herbal medicine for healing purpose from the beginning of human civilization. In recent times, use of evidence-based nutraceuticals for healthcare has increased steadily all over the world although it was neglected for decades by Western societies. The current landscape sees manufacturers and consumers struggle to define the boundaries between the nutrition and pharma as recent innovation draws on disciplines spanning the two sectors. The combination therapy of pharmaceuticals and food bioactive in disease prevention and treatments is one of the most dis-cussed topics in recent time. The transition of the pharmaceutical industry from its traditional business model is ongoing and interesting to see how their next blockbuster molecule could be derived through different routes. The transition from current ‘high-risk, high-margin’ business model to ‘low cost, high volume’ nutra business model is dependent on many factors.
With nutrition and pharma taking lessons from each other, an attempt to be made in this presentation to re-define Nutra(Ayur)ceuticals /functional foods/phytopharmaceuticals as well as to summarize the application of nutraceuticals.)
Biography:
Dr. Dilip Ghosh has received his PhD in biomedical science from India & post-doc from USDA-ARS, HNRCA at Tufts University, Boston. He is an international speaker, facilitator and author and professionally associated with Nutriconnect, Australia; Adjunct-Industry Fellow, NICM Health Research Institute, Western Sydney University. He is also an Adjunct Professor, Kasturba Health Society, Medical Research Center, Mumbai, Jamia Hamdard University at Food Technology, Delhi, India & Visiting Professor, Tehran University of Medical Sciences, Iran. He is a fellow of American College of Nutrition (ACN), professional member of Australian Institute of Food Science & Technology (AIFST), an advisor and executive board member of Health Foods and Dietary Supplements Association (HADSA), The Society for Ethnopharmacology, India (SFE-India), Council for Ayurveda Research, USA, Australasian Ayurvedic Association, Australia and also in editorial board of several journals. He is also on board of Vitafoods Content Advisory Committee. His research interest includes oxidative stress, bioactive, clinically proven functional food and natural medicine development, regulatory and scientific aspects of functional foods, nutraceuticals and herbal medicines.
Dr. Ghosh has published more than 100 papers in peer reviewed journals, numerous articles in food and nutrition magazines and books. His few recent books, “Pharmaceutical to Nutraceutical: A Paradigm shift in disease prevention” & “Natural Medicines-Clinical efficacy, Safety and Quality” under CRC Press, USA has been published in 2017 & 2019. His more recent books, “Nutraceutical in Brain Health & beyond” & “Fenugreek-Traditional & Modern Medicinal Uses” are recently published by Elsevier/Academic Press & CRC Press. His new book, “Nutrition science, marketing nutrition, health claims and public policy” is published by Academic Press/Elsevier last year. Dr Ghosh is also a recipient of IASTAM¬—Zandu Oration Award 2022-23
